ATAGI update following weekly COVID-19 meeting – 25 May 2022
Latest recommendation updatesRecent ATAGI considerationsOn Wednesday 25 May 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation.
As of 23 May 2022, over 58 million doses of COVID-19 vaccines have been administered in Australia.Following a thorough examination of local and international evidence on the use of COVID-19 vaccines, booster doses and epidemiology, ATAGI have recommended the COVID-19 booster rollout program be expanded.
A winter booster dose is now recommended for people aged 16-64 years who have:The Australian Government has accepted this recommendation and this change will take effect from Monday 30 May 2022.The primary goal of the Australian COVID-19 vaccine program is to minimise the risk of severe disease, including hospitalisation and death, from COVID-19.As such, ATAGI have recommended this change to ensure those who are at greater risk of developing severe disease receive the best possible protection throughout the winter months.Healthy people aged 16 to 64 who do not have a risk factor for severe disease and who have received three doses of COVID-19 vaccine are not recommended to receive a winter booster dose at this time.
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|